Marcel J. Casavant, MD

Marcel J. Casavant, MD, is Division Chief of Toxicology at Nationwide Children’s Hospital and a Clinical Professor of Pediatrics and Emergency Medicine at The Ohio State University College of Medicine and a Clinical Professor in the College of Pharmacy. He also is Medical Director of the Central Ohio Poison Center and Director of the Central Ohio Lead Clinic. His clinical interests include the treatment of poisonings in adults and children, particularly heavy metals intoxication. He works extensively with local and state governments developing effective responses to chemical, biological and radiological terrorism, and is Principal Investigator of an HRSA-funded grant to develop Ohio’s three poison centers as a state resource for terrorism response.

Gender:

• Male

Languages Spoken:

• English

Research Funding*:

• Poison Control Bioterrorism Preparedness, Ohio Department of Health/Health Resources and Services Administration

Medical School

• University of Massachusetts Medical School
  Date Completed: 06/03/1990

Internship

• Ohio State University Medical Center
  Date Completed: 06/01/1991

Residency

• Ohio State University Medical Center
  Date Completed: 06/30/1993

Fellowship

• Nationwide Children's Hospital
  Date Completed: 07/01/1995

Department:

• Pediatrics

Section:

• Toxicology

Speciality:

• Emergency Medicine
  
• Medical Toxicology
  

Date of Appointment at Nationwide Children’s Hospital:

• 01/16/1996

• Warrick BJ, Hill M, Hekman K, Christensen R, Goetz R, Casavant MJ, Wahl M, Mowry JB, Spiller H, Anderson D, Aleguas A, Gummin D, Thomas R, Nezlek C, Smolinske S. 2013. A Nine State Analysis of Designer Stimulant "Bath Salts" Hospital Visits.  Annals of Emergency Medicine. Vol. 2013, no. March: ee.
• Spiller HA, Spyker D, Casavant MJ. 2013. Comparison of US Population Changes with Poisonings Reported to the National Poison Data System (NPDS).  Clinical Toxicology. Vol. 51, no. March: 151-5.
• Casavant MJ, Walson PD, Kelley M. 2013. Untitled, Reply.  Clinical Therapeutics. Vol. 2013, no. March: ee.
• Walson,Philip,D; Halvorsen,Mark; Edge,James; Casavant,Marcel,J; Kelley,Michael,T. 2013. Pharmacokinetic comparison of acetaminophen elixir versus suppositories in vaccinated infants (aged 3 to 36 months): a single-dose, open-label, randomized, parallel-group design.  Clinical therapeutics. Vol. 35, no. 2. (February): 135-140.
• Hays H, Jolliff HA, Casavant MJ. 2012. Letter: the psychopharmacology of agitation: concensus statement of the American Association for Emergency Psychiatry Project BETA psychopharmacology workgroup.  West J Emerg Med. Vol. 13, no. 6. (December): e536.
• Bechtel N, Betz S, Bickert M, Bolton M, CASAVANT M, Eiferman D, Glasgow J, Gray C, Gulker. 2011. Central Ohio ENA Members Coordinate an Augmented TNCC Course for Ohio Army National Guard Colleagues.  Central Ohio Trauma System. Vol. 2011, no. February: e4.
• Casavant MJ, Rothweiler M. 2010. Adolescents and Heroin: Identifying the User and Providing Treatment.  Critical Measures. Vol. 11, no. 2. (September): 9-11.
• Polivka,Barbara,J; Casavant,Marcel; Baker,S,David. 2010. Factors Associated with Healthcare Visits by Young Children for Non-Toxic Poisoning Exposures.  J Community Health. Vol. 35, no. 6. (March): 572-578.
• Casavant MJ, Rothweiler M, Painter J. 2010. Getting Sober: Learning to Live without Drugs and Alcohol, for Families.  Helping Hands.
• Casavant MJ, Laubacher C, Painter J. 2010. Proper Disposal of Medicine.  Helping Hands.
• Casavant MJ, Laubacher C, Painter J. 2010. Medicine Safety.  Helping Hands.
• Casavant MJ, Rothweiler M, Painter J. 2010. Learning to Live Without Drugs and Alcohol, For patients.  Helping Hands.
• Casavant MJ, Griffith JR. 2010. Pediatric Pharmacotherapy Part 1 : The History of Pediatric Drug Therapy: Learning from Errors, Not Trials.  Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11e online version with updates.. Vol. 2010, no. January: e1.
• Casavant MJ, Laubacher C, Painter J. 2010. Buprenorphine/Naloxine Medication Assited Therapy for Detoxification.  Helping Hands.
• Casavant MJ, Griffith JR. 2010. Pediatric Pharmacotherapy Part 2: Pediatric Pharmacokinetics - Why Kids Are Not Small Adults.  Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11e online version with updates.. Vol. 2010, no. January: ee.
• Casavant MJ. 2009. Prednisone - High Triglycerides.  Netwellness.org.
• Casavant MJ, Griffith JRK. 2009. Anabolic Steroid Abuse.  British Medical Journal.
• Casavant MJ. 2009. Detox at Children's Hospital.  Heartbeat. Vol. 21, no. 1. (January): 10-11.
• Phan,Hanna; Casavant,Marcel,J; Crockett,Sarah; Lee,Anthony; Hall,Mark,W; Nahata,Milap,C. 2008. Serotonin syndrome following a single 50 mg dose of sertraline in a child.  Clinical Toxicology (Philadelphia, Pa.). Vol. 46, no. 9. (November): e845.
• Griffith JRK, Spiller HA, Weber JA, Lintner CP, Casavant MJ, Baker SD. 2008. Toxicity from Duloxetine Ingestion.  Clinical Toxicology. Vol. 46, no. 7. (January): e611.
• Griffith JRK, Phan H, Casavant MJ, Nahata MC, Baker SD. 2008. Evaluation of Zolpidem Exposures in the Pediatric Population.  Clinical Toxicology. Vol. 46, no. 7. (January): e599.
• Casavant,Marcel,J; Blake,Kathleen; Griffith,Jill; Yates,Andrew; Copley,Larae,M. 2007. Consequences of use of anabolic androgenic steroids.  Pediatric Clinics Of North America. Vol. 54, no. 4. (August): e677.
• Stojanovski,Sasko,D; Baker,S,David; Casavant,Marcel,J; Hayes,John,R; Robinson,Renee,F; Nahata,Milap,C. 2007. Implications of diphenhydramine single-dose unintended ingestions in young children.  Pediatric Emergency Care. Vol. 23, no. 7. (July): e465.
• Griffith J, Casavant MJ. 2007. Serotonin Syndrome.  Ohio DUR Review.
• Casavant MJ, Blake K, Griffity J, PharmD; Yates A, Copley LLM. 2007. Consequences of use of anabolic androgenic ateroids.  Pediatric Clinics of North America. Vol. 54, no. January: 677-690.
• Stojanovski,Sasko,D; Casavant,Marcel,J; Mousa,Hayat,M; Baker,Peter; Nahata,Milap,C. 2007. Atomoxetine-induced hepatitis in a child.  Clinical Toxicology (Philadelphia, Pa.). Vol. 45, no. 1. (January): e51.
• Casavant, MJ. 2007. Response to “Lost in Translation: Presenting Your Manuscript to the Worldâ€?.  Journal of Medical Toxicology. Vol. 3, no. 3. (January): e141.
• Casavant MJ. 2007. Poison in the Playroom.  Community Health.
• Robinson R, Mujumdar M, Griffith J, Casavant M, Baker S. 2007. Therapeutic error: Carboprost Tromethamine Given to a Newborn Intramuscularly.  The Internet Journal of Pediatrics and Neonatology. Vol. 6, no. 2. (January): eonline.
• Polivka,B,J; Salsberry,P; Casavant,M,J; Chaudry,R,V; Bush,D,C. 2006. Comparison of parental report of blood lead testing in children enrolled in Medicaid with Medicaid claims data and blood lead surveillance reports.  Journal Of Community Health. Vol. 31, no. 1. (February): 43-55.
• Casavant MJ. 2006.  Journal of the American Medical Association. Vol. 295, no. 23. (January): 2791-2792.
• Casavant,M,J. 2006. Check emergency department victims for radiation.  Annals Of Emergency Medicine. Vol. 47, no. 1. (January): 120; author reply 120-1.
• Ekleberry S, Casavant MJ. 2006. Acetaminophen Toxicity, Treat the Level, Not the Patient.  Critical Measures. Vol. 7, no. 1. (January): 6-7.
• Casavant MJ. 2006. Evaluation of the Be Poison Smart! Poison Prevention Intervention.  Clinical Toxicology. Vol. 44, no. January: 109-114.
• Casavant MJ. 2006. Indications for Hemodialysis in Toxicology.  The Antidote. Vol. 11, no. 2. (January): 2-2.
• Casavant,M,J. 2006. Antibiotic not linked to autism.  Medical Hypotheses. Vol. 66, no. 3. (January): e678.
• Casavant MJ, Ekleberry S, Lukens E. 2006. Banned Ephedra, Still a Threat.  Critical Measures. Vol. 7, no. 1. (January): 4-5.
• Polivka,B,J; Casavant,M,J; Malis,E; Baker,D. 2006. Evaluation of the Be Poison Smart! poison prevention intervention.  Clinical Toxicology (Philadelphia, Pa.). Vol. 44, no. 2. (January): e109.
• Stojanovski,Sasko,D; Robinson,Renee,F; Baker,S,David; Casavant,Marcel,J; Hayes,John,R; Nahata,Milap,C. 2006. Children & Adolescent Exposures to Atomoxetine Hydrochloride Reported to a Poison Control Center.  Clinical Toxicology. Vol. 44, no. January: 243-247.
• Casavant MJ. 2006. Off-Label/Alternative Uses of Prescribed Medications: The Other Side of the Story.  Pediatric Directions.
• Casavant MJ. 2005. Post-Katrina Medical Intelligence: Preparing Teams to Deploy – United States. Atlanta, GA.  : CDC Epi-X Epidemic Information Exchange System.
• Baker SD, Casavant MJ. 2005. Possible Excessive Toxicity from Water Repellant Spray for Shoes – Ohio.  CDC Epi-X Epidemic Infomration Exchange System.
• Smolinske S, White S, Daubert GP, Didrichsons R, Eisenga B, Mowry J, Mrvos R, Krenzelok E, Casavant MJ, et al. 2005. Illness Associated with Boot Sealant Products --- Five States.  Morbidity * Mortality Weekly Report. Vol. 55, no. 17. (January): 488-490.
• Casavant MJ. 2005. The poison center: prepared for terrorism.  HealthBeat. Vol. 1, no. 3. (January): 2-4.
• Casavant MJ. 2005. Pediatric Antidote Administration During Mass Casualty Event.  Critical Measures. Vol. 5, no. 4. (January): 8-9.
• Bourekas,E,C; Slivka,A,P; Casavant,M,J. 2005. Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent.  Neurocritical Care. Vol. 2, no. 2. (January): e179.
• Robinson RF; Baker RS; Martin S; Casavant MC. 2004. Use of "Near Middle East Antivenom" to treat African bush viper envenomation.  Veterinary And Human Toxicology. Vol. 46, no. 5. (October): e264.
• Robinson,R; Nahata,M; Mahan,J; Casavant,M. 2004. Potential heavy metal exposure from tiger tail cucumber (Holothuria thomas) envenomation.  Veterinary And Human Toxicology. Vol. 46, no. 4. (August): e225.
• Robinson,R,F; Griffith,J,R; Nahata,M,C; Mahan,J,D; Casavant,M,J. 2004. Herbal weight-loss supplement misadventures per a regional poison center.  The Annals Of Pharmacotherapy. Vol. 38, no. 5. (May): e787.
• Robinson,R,F; Casavant,M,J; Nahata,M,C; Mahan,J,D. 2004. Metabolic bone disease after chronic antacid administration in an infant.  The Annals Of Pharmacotherapy. Vol. 38, no. 2. (February): e265.
• Robinson RF, Nahata MC, Mahan JM, Casavant MJ. 2004. Potential Heavy Metal Exposure From Tiger Tail Cucumber (Holothuria thomas) envenomation.  Veterinary & Human Toxicology. Vol. 46, no. 4. (January): 225-225.
• Robinson RF, Casavant MJ, Nahata MC, Mahan JD. 2004. Metabolic Bone Disease after Chronic Antacid Administration in an Eight-Month Old Child.  Annals of Pharmacotherapy. Vol. 38, no. January: 265-268.
• Robinson RF, Griffith JR, Nahata MC, Mahan JM, Casavant MJ. 2004. Herbal Dietary Supplement Ingestions: A Case Series.  Annals of Pharmacotherapy. Vol. 38, no. 5. (January): 787-790.
• Casavant MJ. 2004. Terrorism: Biological, Chemical, and Nuclear.  Journal of Homeland Security and Emergency Management. Vol. 1, no. 3. (January).
• Casavant MJ. 2003. Update on GI Decontamination.  The Antidote. Vol. 9, no. 3. (January): 1-1.
• Casavant MJ, Ekleberry S, Lukens E. 2003. Ephedra Alkaloids: Potential for Toxicity.  Pediatric Directions. Vol. 1, no. Summer. (January): e1.
• Casavant MJ. 2003. Ipecac Alert.  The Antidote. Vol. 9, no. 3. (January): 1-1.
• Casavant,M,J; Fitch,J,A. 2003. Fatal Hypernatremia from Saltwater Used as an Emetic.  Journal of Toxicology, Clinical Toxicology. Vol. 41, no. 6. (January): 861-863.
• Wolowich,W,R; Hadley,C,M; Kelley,M,T; WALSON,P,D; Casavant,M,J. 2003. Plasma Salicylate from Methyl Salicylate Cream Compared to Oil of Wintergreen.  Journal of Toxicology, Clinical Toxicology. Vol. 41, no. 4. (January): 355-358.
• Casavant,M,J. 2002. Urine drug screening in adolescents.  Pediatric Clinics Of North America. Vol. 49, no. 2. (April): e317.
• Casavant,M,J; Shah,M,N; Battels,R. 2002. Urine fluorescence: Is it a good test for ethylene glycol ingestion? Reply.  PEDIATRICS. Vol. 109, no. 2. (February): 345-345.
• Casavant MJ. 2002.  Journal of the American Medical Association. Vol. 288, no. 16. (January): 2052-2052.
• Casavant MJ. 2002. Toxicology and Overdose. In Adolescent Medicine Secrets. Edited by Holland-Hall C, Brown RT. Philadelphia: Hanley and Belfus.
• Wolowich,W,R; Casavant,M,J; Ekins,B,R. 2001. Phenylpropanolamine and hemorrhagic stroke.  The New England Journal Of Medicine. Vol. 344, no. 14. (April): e1094.
• Casavant MJ. 2001. Fomepizole for Toxic Alcohol Poisoning, invited Commentary.  Pediatrics. Vol. 107, no. 1. (January): 170-171.
• Casavant MJ. 2001. Getting to know your poison center.  Critical Measures. Vol. 2, no. January: 5-9.
• Casavant MJ, Shah MN, Battles R. 2001. Fluorescent Urine Does Not Indicate Ethylene Glycol Antifreeze Ingestion.  Pediatrics. Vol. 107, no. 1. (January): 113-114.
• Casavant MJ. 2001. Hospital Personnel are on the Front Lines.  Med Stat.
• Lohani S, Ekins BR, Casavant MJ. 2001. Lead Poisoning.  Access. Vol. 4, no. 1. (January).
• Casavant,M,J; Shah,M,N; Battels,R. 2001. Does fluorescent urine indicate antifreeze ingestion by children?.  Pediatrics. Vol. 107, no. 1. (January): e113.
• Casavant MJ. 2001. Fomepizole in the treatment of poisoning.  Pediatrics. Vol. 107, no. 1. (January): e170.
• Casavant MJ. 2001.  Journal of the American Medical Association. Vol. 286, no. January: 2876-2876.
• Casavant MJ. 2001. Digitalis Toxicology. In Handbook of Cardiovascular Emergencies. 2nd ed. Edited by J. Hoekstra. Boston: Little Brown Publishers.
• Wolowich WR; Casavant MJ; Fisher CA. 2001. Age-specific and age-adjusted penetrance as poison center outcome measures.  Journal Of Toxicology. Clinical Toxicology. Vol. 39, no. 4. (January): e367.
• Wolowich,W,R; Casavant,M,J; Fisher,C,A. 2001. Age-Specific and Age-Adjusted Penetrance as Poison Center Outcome Measures.  Journal of Toxicology, Clinical Toxicology. Vol. 39, no. 4. (January): 367-370.
• Wolowich WR; Casavant MJ. 2000. Toxic acetaminophen doses are toxic or do you know where your acetaminophen is today?.  Pharmacotherapy. Vol. 20, no. 7. (July): e862.
• Casavant,M,J. 2000. Assessment of clinical policy for the initial approach to patients presenting with acute toxic ingestion or dermal or inhalation exposure.  Annals Of Emergency Medicine. Vol. 35, no. 2. (February): e196.
• Casavant MJ. 2000. Review of: "Recognition and Management of Pesticide Poisonings".  Journal of the American Medical Association. Vol. 283, no. 17. (January): 2304-2304.
• Casavant, MJ. 1999. Internet Sources of Toxicology Information for the Developing Nation,." . (Jan 1999) (Published). In Second Annual SAARC Conference
• Lohani S, Ekins BR, Casavant MJ. 1999. Management of Organochlorine Poisoning,.  Access. Vol. 2, no. January: 2-2.
• Casavant MJ. 1999. Internet Sources of Toxicology Information for the Developing Nation,.  Proceedings for Second Annual SAARC Conference.
• Casavant MJ. 1999. Lead Poisoning in Developing Nations.  Proceedings for Second Annual SAARC Conference.
• Walson PD, Casavant MJ. 1998. Lidocane. In Clinical Management of Poisoning and Drug Overdose, 3rd ed.. 3rd ed. Edited by Haddad LM, Shannon MW, Winchester JF. Philadelphia: WB Saunders Company.
• Casavant MJ, Walson PD, Wolowich W, Kelley M. 1998. Near Fatal Ingestions of Household Lamp Oil.  Morbidity & Mortality Weekly Report. Vol. 47, no. 41. (January): 880-882.
• Casavant MJ. 1997. Digitalis Toxicity. In Handbook of Cardiovascular Emergencies. First ed. Edited by J Hoekstra. Boston, MA: Little Brown Publishers.
• Casavant MJ. 1995. Polle's syndrome (Munchausen by proxy).  Pediatric Emergency Care. Vol. 11, no. 4. (August): e264.
• Casavant,M,J. 1995. UNTITLED.  PEDIATRIC EMERGENCY CARE. Vol. 11, no. 4. (August): 264-264.
• Casavant, MJ. Lost in Translation: Presenting Your Manuscript to the World (response). Journal of Medical Toxicology 3(3): 141, September 2007.
• Griffith J, Casavant MJ. Serotonin Syndrome. Ohio DUR Review, May 2007.
• Casavant MJ, Blake K, Griffith J, Yates A, Copley LM. Consequences of Use of Anabolic Androgenic Steroids. Pediatric Clinics of North America 54: 677-690, August 2007.
• Robinson R, Mujumdar M, Griffith J, Casavant M, Baker S. Therapeutic Error: Carboprost Tromethamine Given to a Newborn Intramuscularly. The Internet Journal of Pediatrics and Neonatology 6(2), 2007.